Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 2/20 | 0.71 |
| ▸ | F13A1 | P00488 | 1/20 | 0.64 |
| ▸ | ELANE | P08246 | 13/20 | 0.56 |
| ▸ | PLG | P00747 | 6/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18094962 | 0.85 | F10 (0.86) | F10F13A1ELANEPLG | |
| SCHEMBL18094964 | 0.84 | F10 (0.84) | F10F13A1ELANEPLG | |
| SCHEMBL18102775 | 0.84 | ACE2 (0.58) | ELANEPLGACE2 | |
| SCHEMBL5072262 | 0.82 | F10 (0.72) | F10F13A1PLGACE2 | |
| SCHEMBL18102777 | 0.82 | F10 (0.79) | F10F13A1ELANEPLGACE2 | |
| SCHEMBL8015255 | 0.75 | TUBB4A (0.67) | F10ELANE | |
| SCHEMBL6122217 | 0.74 | ACE2 (0.59) | F10F13A1ELANEPLGACE2 | |
| SCHEMBL3642770 | 0.73 | TUBB4A (0.69) | F10 | |
| SCHEMBL19749974 | 0.72 | ACE2 (0.72) | PLGACE2 | |
| SCHEMBL18102797 | 0.72 | ACE2 (0.58) | PLGACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160280676-A1 | SULFATED AND UNSULFATED FLAVONOID OLIGOMERS AS CANCER THERAPEUTICS | VIRGINIA COMMONWEALTH UNIVERSITY | 2016-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160280676-A1 | SULFATED AND UNSULFATED FLAVONOID OLIGOMERS AS CANCER THERAPEUTICS | CD44, UGGT1, TSG101 | F10 745/4885F13A1 1381/4885ELANE 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.